🇺🇸 Rosuvastatin calcium 40mg in United States

10 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Asthenia — 1 report (10%)
  2. Decreased Appetite — 1 report (10%)
  3. Disturbance In Attention — 1 report (10%)
  4. Fatigue — 1 report (10%)
  5. Lethargy — 1 report (10%)
  6. Liver Injury — 1 report (10%)
  7. Loss Of Personal Independence In Daily Activities — 1 report (10%)
  8. Muscle Spasms — 1 report (10%)
  9. Pain — 1 report (10%)
  10. Renal Disorder — 1 report (10%)

Source database →

Rosuvastatin calcium 40mg in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Rosuvastatin calcium 40mg approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Rosuvastatin calcium 40mg in United States?

Seung-Jung Park is the originator. The local marketing authorisation holder may differ — check the official source linked above.